Marcus W Bosenberg (Marcus Bosenberg)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Ulcerative Colitis

Dendritic Cells

Immune Response

Top Venues

Molecular cancer research : MCR

Clinical & experimental metastasis

British journal of cancer

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Kailash Chandra Mangalhara, Siva Karthik Varanasi, Melissa A Johnson, Mannix J Burns, Gladys R Rojas, Pau B Esparza Moltó, Alva G Sainz, Nimesha Tadepalle, Keene L Abbott, Gaurav Mendiratta, Dan Chen, Yagmur Farsakoglu, Tenzin Kunchok, Filipe Araujo Hoffmann, Bianca Parisi, Mercedes Rincon, Matthew G Vander Heiden, Marcus W Bosenberg, Diana C Hargreaves, Susan M Kaech, Gerald S Shadel
Manipulating mitochondrial electron flow enhances tumor immunogenicity. Science (New York, N.Y.) 381 (6664) (2023)
Irina Krykbaeva, Kate Bridges, William E Damsky, Gabriela A Pizzurro, Amanda F Alexander, Meaghan K McGeary, Koonam Park, Viswanathan Muthusamy, Jim Eyles, Nadia Luheshi, Noel Turner, Sarah A Weiss, Kelly Olino, Susan M Kaech, Harriet M Kluger, Kathryn Miller-Jensen, Marcus W Bosenberg
Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance. Cancer immunology research (2023)
Hong Yan, Ronan Talty, Oladimeji Aladelokun, Marcus W Bosenberg, Caroline H Johnson
Ferroptosis in colorectal cancer: a future target? British journal of cancer (2023)
Sarah E Fenton, Markella Zannikou, Markella Zannikou, Mariafausta Fischietti, Chunni Ji, Chidera V Oku, Curt M Horvath, I Caroline Le Poole, Marcus W Bosenberg, Elizabeth Thomas Bartom, Masha Kocherginsky, Leonidas C Platanias, Diana Saleiro
Targeting ULK1 decreases interferon-γ-mediated resistance to immune checkpoint inhibitors. Molecular cancer research : MCR (2022)
Sarah E Fenton, Markella Zannikou, Markella Zannikou, Mariafausta Fischietti, Chunni Ji, Chidera V Oku, Curt M Horvath, I Caroline Le Poole, Marcus W Bosenberg, Elizabeth Thomas Bartom, Masha Kocherginsky, Leonidas C Platanias, Diana Saleiro
Targeting ULK1 decreases interferon-γ-mediated resistance to immune checkpoint inhibitors. Molecular cancer research : MCR (2022)
William E Damsky, Alice Wang, Daniel J Kim, Bryan D Young, Katelyn Singh, Michael J Murphy, Joseph Daccache, Abigale Clark, Ruveyda Ayasun, Changwan Ryu, Meaghan K McGeary, Ian D Odell, Ramesh Fazzone-Chettiar, Darko Pucar, Robert J Homer, Mridu Gulati, Edward J Miller, Marcus W Bosenberg, Richard A Flavell, Brett A King
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nature communications 13 (1) (2022)
Goran Micevic, Marcus W Bosenberg, Qin Yan
The crossroads of cancer epigenetics and immune checkpoint therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Shang-Min Zhang, Wesley L Cai, Xiaoni Liu, Durga Thakral, Jiesi Luo, Lok Hei Chan, Meaghan K McGeary, Eric Song, Kim R M Blenman, Goran Micevic, Shlomit Jessel, Yangyi Zhang, Mingzhu Yin, Carmen J Booth, Lucia B Jilaveanu, William E Damsky, Mario Sznol, Harriet M Kluger, Akiko Iwasak, Marcus W Bosenberg, Qin Yan
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature 598 (7882) (2021)
Noel Turner, Olivia Ware, Marcus W Bosenberg
Genetics of metastasis: melanoma and other cancers. Clinical & experimental metastasis 35 (5-6) (2018)